Ropes & Gray advised Intermediate Capital Group on the transaction, Willkie Farr & Gallagher advised Law Business Research and Levine Leichtman Capital Partners. Intermediate Capital Group...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Erasca, Inc. on the deal. Erasca, Inc. (Nasdaq: ERAS), a precision oncology company, announced it has entered into an exclusive license agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Adaptimmune Therapeutics plc on the transaction, and DLA Piper advised Hercules Capital. Adaptimmune Therapeutics plc (NASDAQ: ADAP), a clinical-stage biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Dessert Holdings in the transaction, and Holland & Knight represented Kenny’s Great Pies. Dessert Holdings®, North America’s premium dessert company, announced that...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Zaxby’s in the deal. Zaxby’s, the franchisor known for its chicken wings and fingers, announced it has executed a new issuance of...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised FogPharma on the transaction. FogPharma announced a collaboration with ARTBIO Inc. to co-develop new radiopharmaceuticals that would use FogPharma’s Helicon peptides platform,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Fulcrum Therapeutics on the transaction. Fulcrum Therapeutics, Inc. (Fulcrum) (Nasdaq: FULC) announced it has entered into a collaboration and license agreement with...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Gilgamesh Pharmaceuticals in a transaction. Gilgamesh Pharmaceuticals announced it has entered into a collaboration and option-to-license agreement with AbbVie (NYSE: ABBV) to...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Novavax Inc. in the transaction. Novavax Inc.(Nasdaq: NVAX) announced it has entered into a co-exclusive licensing agreement with French pharmaceutical company Sanofi...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Novo Nordisk on the transaction. Novo Nordisk announced it has entered into a research collaboration agreement with Flagship Pioneering and Metaphone Biotechnologies,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray acted as special counsel to TCW ETF Trust in the transaction. The TCW Group (“TCW”), a global asset management firm, announced that it...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Chiesi Group on the transaction, and Latham & Watkins advised Gossamer Bio. Chiesi Group announced it has entered into a global collaboration...
You must be a Standard 1 Year member to access this content.
